Chicago Cornea Consultants Logo

Randy J. Epstein, M.D., Bibliography

PEER-REVIEW JOURNAL ARTICLES

  1. Epstein RJ, Hughes WF: “Lymphocyte-induced corneal neovascularization: A morphologic assessment”. Invest Ophthalmol Vis Sci 21 (1):87-94, 1981.
  2. Miller MT, Epstein RJ, Sugar J, et. al.: “Anterior segment anomalies associated with the fetal alcohol syndrome”. J Ped Ophthalmol and Strabismus 21:8, 1984.
  3. Epstein RJ, Wilson LA, Visvesvara GS, Plourde E: “Rapid diagnosis of Acanthamoeba keratitis from corneal scrapings using indirect fluorescent antibody staining”. Arch Ophthalmol 104:1318, 1986.
  4. Epstein RJ, Halkias A, Stulting RD, and Rodrigues MM: “Corneal opacities and anterior segment anomalies in DBA/2 mice: Models for corneal elastosis and the iridocorneal endothelial (ICE) syndrome”. Cornea 5:95, 1986.
  5. Epstein RJ, Fernandes A, Stulting RD, Tigges M, Wright JD, and Gammon JA: “The correction of aphakia in neonatal monkeys with extended-wear contact lenses: Corneal studies”. Ophthalmology 93: 1495, 1986.
  6. Epstein RJ, Stulting RD, and Kindle JC: “Blastogenesis induced by Herpes simplex virus in splenic mononuclear cells from inbred mice”. Curr. Eye Res. 6:145, 1987.
  7. Epstein RJ, and Stulting RD: “Corneal neovascularization induced by stimulated lymphocytes in inbred mice”. Invest Ophthalmol Vis Sci 28: 1505, 1987.
  8. Epstein RJ, Seedor JA, Dreizen NG et al.: “Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival”. Ophthalmology 94: 935, 1987.
  9. Epstein RJ, Stulting RD, Hendricks RL, Harris DM: “Corneal neovascularization: Pathogenesis and inhibition”. Cornea 6:250-257, 1987.
  10. Moore MB, McCulley JP, Newton C, Cobo LM, Foulks G, O’Day D, Johns K, Driebe WT, Wilson LA, Epstein RJ, Doughman DJ: “Acanthamoeba keratitis: A growing problem in soft and hard contact lens wearers”. Ophthalmol 94: 1654,1987.
  11. Epstein RJ, Fernandes A, Gammon JA: “The correction of aphakia in infants with hydrogel extended-wear contact lenses: Corneal studies.” Ophthalmol 95: 1102-1106, 1988.
  12. Visvesvara GS, Epstein RJ, et al: “Acanthamoeba keratitis associated with contact lenses-United States”. Morbidity and Mortality Weekly Report 35:405, 1988.
  13. Driebe WT Jr., Stern GA, Epstein RJ, Visvesvara GS, Adi M, Komadina T: “Acanthamoeba keratitis: Potential role for topical clotrimazole in combination chemotherapy”. Arch Ophthalmol 106:1196-1201, 1988.
  14. Epstein RJ, Vastine DW, Fried WI: “Removing the Stableflex intraocular lens during penetrating keratoplasty”. Ophthalmic Surg 20:171-172, 1989.
  15. Hendricks RL, Epstein RJ, Tumpey T: “The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis in mice”. Invest Ophthalmol Vis Sci. 30:105-115, 1989.
  16. Epstein RJ, Hendricks RL, Stulting RD: “Interleukin-2 induces corneal neovascularization in A/J mice”. Cornea 9:318-323, 1990.
  17. Hendricks RL, Barfknecht CF, Schoenwald RD, Epstein RJ, Sugar J: “The effect of flurbiprofen on herpes simplex virus type I stromal keratitis in mice”. Invest Ophthalmol Vis Sci 31:1503-1511, 1990.
  18. Hendricks RL, Epstein RJ, Viana MAG, Hoffman DA: “A reproducible method for injecting the mouse corneal stroma”. Invest Ophthalmol Vis Sci 32:366-370, 1991.
  19. Epstein RJ, Hendricks RL, Harris DM: “Photodynamic therapy for corneal neovascularization”. Cornea 10:424-432, 1991.
  20. Holland EJ, Alul IH, Meisler DM, Epstein RJ, et al.: “Subepithelial infiltrates in Acanthamoeba keratitis”. Am J Ophthalmol 112:414-418, 1991.
  21. Lipman RM, Epstein RJ, Hendricks RL: “Suppression of corneal neovascularization by cyclosporine”. Arch Ophthalmol 110:405-407, 1992.
  22. Nelson JD, Gordon JF, and the Chiron Keratoconjunctivitis Sicca Study Group: “Topical fibronectin in the treatment of keratoconjunctivitis sicca.” Am J Ophthalmol 114:441-447, 1992.
  23. Kay MD, Epstein RJ, Torczynski E: “Histopathology of acute intraoperative suprachoroidal hemorrhage associated with transscleral intraocular lens fixation”. J Cataract Refract Surg 19:83-87, 1993.
  24. Epstein RJ, Eiden SB: “Circumscribed posterior keratoconus”. J. Am. Optom Assn., 66:189-193, 1995.
  25. Baca LS, Epstein RJ: “Closed-chamber capsulorhexis for cataract extraction combined with penetrating keratoplasty”. J Cataract Refract Surg: 24: 581-584, 1998.
  26. Karp KO, Flood TP, Wilder AL, Epstein RJ: “Photic Maculopathy after Pterygium Excision”, AJO 128; 248-250, 1999.
  27. Konowal A, Morrison JC, Brown SVL, Cooke DL, Maguire LJ, Verdier DV, Fraunfelder FT, Dennis RF, Epstein RJ: “Irreversible corneal decompensation in patients treated with topical dorzolamide”, Am J Ophthalmol 127; 403-406, 1999
  28. Majmudar PA., Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R, Epstein RJ: “Topical Mitomycin-C for subepithelial fibrosis after refractive corneal surgery”, Ophthalmol., 107:89-94, 2000.
  29. Karp KO, Hersh PS, Epstein RK: “Delayed keratitis after laser in-situ keratomileusis”, J Cataract Surg, 26: 925-928, 2000.
  30. Rao SN, Epstein RJ: Early onset ectasia following laser in-situ keratomileusis: Case report and literature review”. J. Refr. Surg 18: 177-184, 2002.
  31. Tang-Liu, DDS, Small D, Acheampong A, Reis B, Stern K, Stewart W, Berdy G, Epstein RJ, Forster R, Forstot L: “Blood concentrations of cyclosporin A during long-term treatment with cyclosporin A ophthalmic emulsions in patients with moderate to severe dry eye disease.” J Ocular Pharmacol and Therapeutics, 2002
  32. Rao S, Raviv T, Majmudar PA, Epstein RJ: “Role of ORBScan II in screening kerato-conus suspects before refractive corneal surgery”. Ophthalmol 109:1642-1646, 2002,
  33. Rao S, Konowal A, Murchison AE, Epstein RJ: “Enlargement of the temporal clear corneal incision to treat pre-existing astigmatism.” J Refract Surg 18:463-467. 2002.
  34. Muller LT, Candal EM, Epstein RJ, Dennis RF, Majmudar PA: “Transepithelial phototherapeutic keratectomy/photorefractive keratectomy (PTK/PRK) with adjunctive mitomycin-C for complicated LASIK flaps”. J Cat Refr Surg 31: 291-296, 2005
  35. Spanggord HM, Epstein RJ, Lane HA, Candal, EM, Klein, SR, Majmudar PA, Dennis RF: “Flap Suturing with Proparacaine For Recurrent Epithelial Ingrowth Following LASIK Surgery”. J Cat Refr Surg 31:916-921, 2005.
  36. Sheppard, JD, Epstein, RJ, Lattanzio FA, Marcantonio, D and Williams, PB: Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphrin ether. Am J Ophthalmol 141: 524-529, 2006.
  37. Klein, SR, Epstein RJ, Randleman JB, and Stulting RD: “Corneal ectasia after laser-in situ keratomileusis in patients without apparent preoperative risk factors. Cornea 25: 388-403, 2006.
  38. Majmudar, PA Epstein RJ, Parent A, Raphtis EM, Grostern R, Torczinski E. : Noninvasive diagnosis of epithelial downgrowth after penetrating keratoplasty using immunohistochemical analysis of resected corneal buttons. Cornea 25:727-733, 2006.
  39. Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, Edelhauser HF: “Effect of Mitomycin C on the Corneal Endothelium When Used for Corneal Subepithelial Haze Prophylaxis Following Photorefractive Keratectomy.” J Refract Surg. 23:724-727, 2007
  40. Davis, MJ, Epstein, RJ, Dennis, RF, and Cohen JA: “Culture-positive endophthalmitis after implantation of intraocular Collamer lens”. J Cat Refr Surg 35: 1826-28, 2009
  41. Virasch, V, Majmudar PA, Epstein RJ, et al: “Reduced Application Time for Prophylactic Mitomycin-C in Photorefractive Keratectomy”. Ophthalmol. 117: 885-89, 2009
  42. Elderkin, SJ, and Epstein, RJ, Seldomridge DL:“Successful Treatment of Recurrent Epithelial Ingrowth Associated With Interface Fluid Syndrome, Flap Necrosis, and Epithelial Defects Following LASIK” J Refract Surg 27:70, 2011.
  43. Lane SS, Dubiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald JE, Silbert DI, Blackie CA, Stevens CA, and Bedi R : A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 31 :396-404, 2012
  44. Hou JH, Tannan A, Rubenstein JB, Lopez OI, McCoy K, Epstein RJ, Grostern RJ, Sugar J : Clostridium Perfringens endophthalmitis after penetrating keratoplasty with contaminated corneal allografts : A case series. Cornea 34:23-27, 2015
  45. Dalal,R.R.; Raber,I.; Dunn,S.P.; Weisenthal,R.; Sugar,J.; Hannush,S.; Epstein,R.; Feder,R.S.: Epithelial ingrowth following endothelial keratoplasty, Cornea 35: 465-470, 2016
  46. Rubinfeld RS, Epstein RH, Majmudar PA, Kim D, Choi M, and Epstein RJ : Transepithelial crosslinking retreatment of progressive corneal ectasia unresponsive to classic crosslinking. J Cat Ref Surg 43 : 131-135, 2017

INVITED ARTICLES, BOOK CHAPTERS

Non-Peer Review/“Tabloid” Articles Written, Edited, or Quoted in

  1. Epstein RJ and Waring GO, III: Aging and the cornea. Part 1. Conditions not associated with visual impairment. Geriatric Ophthalmol 1:20-30, 1985.
  2. Epstein RJ and Waring GO, III: Aging and the cornea. Part 2. Conditions that may lead to visual impairment Geriatric Ophthalmol 1:17-23, 1985.
  3. Epstein RJ, Allen RC, and Lunde MW: Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma. Ann Ophthalmol 19:48, 1987.
  4. The Institute of Medicine of Chicago. Epstein RJ: Immunologic diseases of the anterior segment of the eye: Local and systemic. Proc Inst Med Chgo 42:52, April, 1989.
  5. Hennessey MJ, Epstein RJ: Preventing violation of optical zone during RK. Ocular Surgery News 11:97, 1993.
  6. Sjogren’s Syndrome Foundation National Newsletter, “The Moisture Seekers”. “Pharmacologic and surgical therapeutics for the dry eye”, March, 1994.
  7. Management of astigmatism during cataract surgery: Round table discussion: Maloney WF, Epstein RJ, Wallace RB, Kershner RM, Alpins NA, Richman RA: Ocular Surgery News, February, 1995 pp. 13-16.
  8. Epstein RJ: Life in a suburb: Physician cooperation brings RK to town, Ocular Surgery News 13:17, 1995.
  9. Epstein RJ, Kormehl E: Watch for decompensation with Trusopt. Ophthalmology Times, (O.T.) 22:12, 1997.
  10. Epstein RJ: LASIK can create happy patients and even happier staffs. O.T., 7/1/97
  11. Epstein RJ: Bilateral LASIK requires error-free surgery every time. O.T., 10/98
  12. Raviv T, Epstein RJ: Flat cornea and diplopia. Annals of Ophthalmology 2000: 32(2) 85-86.
  13. Raviv T, Epstein J, Majmudar PA: Mitomycin-C debridement can treat post-PRK haze. Ophthalmology Times, 2/00.
  14. Raviv T, Majmudar PA, Dennis RF, and Epstein RJ: Oxygen drying technique assures LASIK flap adherence. Ophthalmology Times, June, 2000.
  15. Rao SR, Majmudar PA, Epstein RJ: “Topography system can image posterior surface of cornea”, Ophthalmology Times, 26, No. 13, pg. 14, 2001.
  16. Epstein RJ: “Randy Epstein on Personal Experience of LTK”, Refractive Eyecare for Ophthalmologists 5:1, 2001.
  17. Rao S, Epstein RJ: “Large Study Finds Voltaren Safe Following Cataract Surgery”, Ocular Surgery News 19, No. 19; 12, 2001.
  18. Epstein RJ: Optimizing patient outcomes when using laser technology for refractive surgery. Ophth Management Suppl., 11/01, pg. 12-14.
  19. Epstein RJ, Muller LT, Spanggord HM: “Preventing glare and halos following LASIK surgery”. Ophthalmology Management (Suppl.), 9/02.
  20. Epstein, RJ et. al: “Risk management guidelines for refractive surgery”, Illinois State Medical Society Insurance Services (ISMSIS). Ophthalmology Risk-Management Sub-committee document (2002).
  21. Muller LT, Majmudar PA, Epstein RJ: “Mitomycin-C for post-PRK haze and complicated LASIK flaps”. Review of Refractive Surg. 4:15-17, 2003.
  22. Candal EM and Epstein RJ: “IOL selection issues after RK”. Cat Ref Surg Today 3: 34-38, 2003.
  23. Muller LT, Packo KH, Spanggord HM, Epstein RJ: “Band keratopathy within a LASIK flap”. Cataract & Refract Surg Today 3:32-34, 2003.
  24. Candal, EM, Muller, LT, Dennis RF, Majmudar PA, Klein S, Epstein RJ: “Identifying keratoconus suspects with wavefront analysis”. Ref. Surg. Today 4:52 -56, 2004.
  25. Klein SR, Epstein RJ, Mamalis, N, Werner L: “Late Opacification of the Memory Lens”. Review of Refractive Surgery 5:17-18, 2004.
  26. Klein, Shawn R MD; Epstein, Randy J MD; Majmudar, Parag A MD; Muller, Laura T MD: Management of Complicated or Buttonhole LASIK Flaps with Transepithelial Phototherapeutic Keratectomy/ Photorefractive Keratectomy with Adjunctive Mitomycin C. Tech. in Ophthalmology. 2(3):110-113, Sept., 2004.
  27. Epstein, RJ: “Great expectations: Today’s refractive surgery patient”. Refractive Eyecare for Ophthalmologists 8:1, 2004.
  28. Talsma J. and Epstein, RJ: “Mitomycin-C after surface ablation can prevent corneal haze. Ophthalmology Times, 3/1/04, page 49.
  29. Gonzalez JM: “MMC can be used prophylactically in PTK, PRK to prevent corneal haze”: Ocular Surgery News (O.S.N.) 22: 3, 5/1/04
  30. Candal, EC, Seldomridge DL, Muller LT, and Epstein RJ: Wavefront analysis detects pellucid marginal degeneration before LASIK: O.S.N. 10/15/04, pp. 60-61.
  31. Klein SR, Epstein, RJ, Majmudar, PA, Muller LT: “Management of Complicated or Buttonhole LASIK Flaps With Trans-epithelial Phototherapeutic Keratectomy/ Photorefractive Keratectomy With Adjunctive Mitomycin C”. Techniques in Ophthalmology, Sept. 2004, Vol. 2, pp. 110-113.
  32. Bethke, Walter: “Refractive Surgery: Insights on Ectasia”: Review of Ophthalmology, March 2005, pp. 33-37.
  33. Karmel, Miriam: “Rethinking Mitomycin-C”: EyeNet, March 2005, pp. 35-39
  34. Faron CA and Epstein RJ: “Crystalens postop care similar to phaco cases”. Primary Care Optometry News, Vol. 10., Sept. 2005, p. 38.
  35. Epstein RJ, and Cutler R: “Chicago physician shares popular dining spots”. S.N., Vol. 29, 10/1/05, p. 65.
  36. Klein, SR, Epstein RJ, Randleman JB, Stulting RD: “Ectasia without risk factors”. J Cat Ref Surg Today, July 2005, pp. 32-34.
  37. Guttman, C: “Post-LASIK ectasia possible with no known risk factors”. Ophthalmology Times, 9/15/05, p. 57.
  38. Epstein, RJ, Herst, B, Goren, M, Gerstein, M, Brenner, S: “Exploring Liability Issues in Refractive Eye Surgery “, ISMIE Newsletter, Spring 2006.
  39. Seldomridge DL, Candal EM, Epstein RJ. “Wavefront analysis for keratoconus and Pellucid Marginal Degeneration”. Review of Ophthalmology 2005; 10:96-103
  40. Epstein, RJ, Groves N: “Prophylactic MMC helps prevent haze, improve acuity”. T., 2/1/08, p. 36.
  41. Shovlin JP and Epstein, RJ: “Risk of ectasia worries patient”. Review of Optometry 4/15/08, page 107.
  42. Hasson, M: “Modified DSEK technique promotes graft fixation, prevents complications”.  S.N., 5/10/09, pg. 3.
  43. Boxer Wachler B, Epstein RJ, Brown SVL. Maguen E, Talley-Rostov AR : ‘Complications after the placement of a phakic IOL ‘. Cataract & Refractive Surgery Today, October 2009, pg. 67.
  44. Bethke, W : ‘The best way to straighten a bow tie ‘. Rev. Of Ophthalmol.17 :28-31, Jan. 2010
  45. Chu, R, and Epstein RJ : ‘Rehabilitating a patient with extreme myopic astigmatism ‘. Premier Surgeon Vol. 2, pp. 10-11, 2011.
  46. Menke, Anne : ‘Surgical Team Briefings Reduce Malpractice Risks’ : OMIC Digest Fall 2011, V. 21, #4, page 1.
  47. Guell, J., ed. : ‘Refractive surgical problem’- Randy Epstein, J Cat Ref Surg. 38 :554-559, 2012
  48. “LTK: What I Learned”. Refractive Eyecare 16:1, (May) 2012, edited by Ethis Communications Editorial Director, David Kellner
  49. ‘Easy as 123- Protect your eyes from UV rays’. In ‘Discover Rush’, Summer 2012. (Rush Univ. Medical Center Periodical)
  50. Epstein RJ, Hardten DR, Hovanesian JA, Liang K, Shultz MC : ‘Controlling Perioperative Inflammation’, Cat & Refr Surg Today 12 :14, 2012
  51. Braga-Mele, R, Epstein, RJ, Katsev D, and Updegraff S : ‘Posterior corneal astigmatism and toric IOL’s’ – CRST Today’s topics, ed. by JF Doane, April 2013 :18-19
  52. Epstein, RJ : ‘Preventative eye care goes a long way’- Vision- Spring 2013 (Illinois Eye Bank’s quarterly publication).
  53. Epstein, RJ, Epstein RH, Dennis RF, Majmudar, PA : Response to ‘Consultation Section : Corneal Surgical Problem’, J. Cat Ref Surg, 39 ;1618-1623 : 2013, Sect. Ed. : M. Moshirfar
  54. Lipner, Maxine : ‘Ocular Allergy Treatments’. EyeWorld, Feb. 2014, pp. 14-17
  55. Moshirfar, M., ed : ‘Anterior chamber surgical problem’ : RJ Epstein, JCRS 40 : 683-687, 2014
  56. Moshirfar M., ed. : ‘Corneal surgical problem’ : RJ Epstein, JCRS 40 :1747-1756, 2014
  57. Charters, Lynda : ‘Mitomycin C : Prophylactic, therapeutic, creative benefits’. Ophthalmology Times 2/15/15, p. 30.
  58. Cover Focus, ‘Meet the Epstein Family’ : CATARACT & REFRACTIVE SURGERY TODAY EUROPE | OCTOBER 2016.
  59. Cover Focus, ‘Family Tree : The Epsteins’ : CATARACT & REFRACTIVE SURGERY TODAY Feb., 2017, pp. 41-42
  60. Roach, Linda : ‘HORV and Cataract Surgery, Part 2 : Considering Alternatives to Vancomycin’, EyeNet, March 2017, pp. 27-29
  61. ‘All in the family : The Epstein’s pursuit to provide the gift of sight’. Vision, Fall 2017. (Publication of Eversight Ilinois Eye Bank)

BOOK CHAPTERS

  1. Epstein RJ and Stulting RD: “Immunologically mediated corneal neovascularization in inbred mice”. In: Ocular Circulation and Neovascularization. BenEzra D, Ryan SJ, Glaser BM, and Murphy RP. Eds, Martinus Nijhoff/Dr W. Junk Publ., Dordrecht, Netherlands, 1987, pp. 341-348.
  2. Stulting RD, Abghari SZ, Epstein RJ, Nahmias AJ: “Host control of Herpes simplex virus Type-I (HSV) ocular disease in a genetically defined animal model. In: The Cornea. Trans. of the World Congress on the Cornea III. Cavanagh HD, ed. Raven Press, Ltd., New York, NY, 1988, pp. 405-411.
  3. Epstein RJ: Dendritic keratitis. “Will wiping it off wipe it out?” In: Ophthalmic Clinical Debates. Deutsch TA, ed. Year Book Medical Publishers, Inc., Chicago, IL, 1989, pp . 88-93.
  4. Basic and Clinical Science Course (BCSC), Section 8, “External Disease and Cornea” (with co-authors: Schwab I, Harris, DJ, Pflugfelder, SC, Wilhelmus KR, Perry P), AAO, 1992 edition
  5. Majmudar PA, Epstein RJ, “Antimetabolites in Ocular Surface Neoplasia” Schwab, I-ed. Current Opinion in Ophthalmology 9:IV: 35-39, 1998.
  6. Raviv T, Epstein RJ. “Astigmatism Management”. Int. Ophthalmol. Clin., (Refractive Surgery) 40:3: 183-198, 2000.
  7. Muller LT, Rao SN, Candal EM, Epstein, RJ. “Corneal Ectasia following LASIK Surgery”. In Probst, LE: LASIK: Advances, Controversies, and Custom, 2004 (Chapter 17). Charles Slack, Inc., Thorofare, NJ 08086.
  8. Letko E, Majmudar PA, Forstot SL, Epstein RJ, Rubinfeld RS: “UVA-light and Riboflavin-mediated Corneal collagen cross-linking”. In Trattler, W, Awdeh RM, Goldman DA: “Cornea/Refractive”, Spring 2011 (pp 63-76) Int. Ophthalmol. Clinics V. 51, #2, 2011. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia

BOOKS EDITED

  1. AAO Focal Points Monograph: Surgical Treatment of Pterygium- Gans LA, Vol. 14, #12, 1996. Reviewer and contributing editor.
  2. Gans L, Belin M, Epstein RJ, Wand M: “Surgical Treatment of Astigmatism”. AAO Focal Points Monograph 14: 12, 1996.

OTHER PUBLICATIONS

LETTERS TO THE EDITOR

  1. Epstein RJ, Luskin AT, Rana A: “The polyglandular syndrome”. Ann Int Med 92:711, 1980.
  2. Epstein RJ, Mets MB, Wong PWK, Mizen T: “Uveal colobomas and Klinefelter’s syndrome”. Am J Ophthalmol 98:241-243, 1984.
  3. Epstein RJ, Vastine DW, Fried WI: “Refining the technique for removing the Stableflex lens.” Ophthalmic Surg 20:599, 1989.
  4. Epstein RJ: “Viscoelastic agents”. Ophthalmic Surg 22:240, 1991.
  5. Epstein RJ: “Use of the disposable contact lens as a bandage contact lens”. Arch Ophthalmol 109: 1341, 1991.
  6. Epstein RJ: “Treatment of rheumatoid corneal ulcers”. Ophthalmology 99:842, 1992.
  7. Epstein RJ: “Transverse astigmatic keratotomy”. Refract Corneal Surg 8: 487, 1992.
  8. Epstein RJ: “General anesthesia and AISH”. J Cataract Refract Surg 19: 814, 1993.
  9. Epstein RJ, Robin JB: “Corneal graft rejection episode after excimer laser phototherapeutic keratectomy”. Arch Ophthalmol, 112:157, 1994.
  10. Epstein RJ: “Band keratopathy secondary to Herpes simplex or topical corticosteroid?” Arch Ophthalmol, 112: 578, 1994.
  11. Epstein RJ: “Refractive surgery goes mainstream: Establishing radial keratotomy services at a suburban community hospital”. J Refract Corneal Surg, 10: 378, 1994.
  12. Konowal A, Epstein RJ: “ALK vs. PK”. Ocular Surgery News, 14:4. 1996.
  13. Epstein RJ: “Is advancing wave-like epitheliopathy distinct from whorled microcystic dystrophy?” Ophthalmology, 105: 4, 1998.
  14. Epstein RJ, Brown SVL, Dennis R, Konowal-Allen A: “Accommodation of systemic acetazolamide and topical dorzolamide”. Ophthalmol. 105: 9, 1998.
  15. Epstein RJ: “Combining Keratoplasty and Cataract Surgery”. J Refract Corneal Surg, 25:603, 1999.
  16. Epstein RJ: “Cyclosporine and neovascularization”. Ophth. 106: 3, 1999.
  17. Raviv T, Majmudar PA, Dennis RF, Epstein RJ: “Mitomycin-C for post-PRK haze”. J Cat Ref Surg 26:1105, 2000.
  18. Majmudar PA, Raviv T, Dennis RF, Epstein RJ: “Subepithelial fibrosis after RK”. J Cat. Refract. Surg, 26: 113, 2000.
  19. Epstein RJ: “Extending the Standard Temporal Incision”. J Cat. Refract. Surg, 26: 1697-98, 2000.
  20. Epstein RJ: “Triple Anterior Stromal Ring Infiltrate Associated with Presumed HSV Keratitis”. Cornea 20(8):904-906, 2001.
  21. Rao S, Majmudar PA, Epstein RJ: “Transepithelial PTK/PRK Over Complicated LASIK Flaps”. J. Refract Surg: 17:47, 2001.
  22. Epstein RJ, Majmudar PA: “Pepper Spray in the Eye”. Ophthalmology 108: 1712, 2001.
  23. Epstein RJ: “Effect of topical trifluridine on Thygeson’s superficial punctate keratitis”. Ophthalmology 2002.
  24. Epstein RJ: “Control of Astigmatism in Cataract Surgery”. J Refr Surg 19. 9/03
  25. Epstein RJ, Brown SVL, Konowal A: “Endothelial changes associated with topical dorzolamide do appear to be significant”. Arch Ophthalmol 122;1089, 2004.
  26. Epstein RJ: “Words of praise”. Cat Refr Surg Today 4:15, June 2004
  27. Epstein, RJ and Majmudar, PA: “Alternative approach to the treatment of subepithelial fibrosis following radial keratotomy”.  Arch Ophthalmol 124:288, 2006.
  28. Klein, SR and Epstein RJ: “Ectasia after Photorefractive Keratectomy”. Ophthalmology 114:395-96, 2007.
  29. Epstein, RJ and Rao SN: “Early onset ectasia following LASIK: Long-term follow-up and correction”: J. Refract. Surg. 25: 250, 2009
  30. Larsen, B, Epstein RJ, Brown SVL: “Diagnosis of post-LASIK Chandler syndrome”. J Cat Refract Surg 35:3-4, 2009
  31. Davis, MJ, Packo KH, Epstein, RJ, Grostern RJ, and Cohen JA: Acanthamoeba endophthalmitis following penetrating keratoplasty for Acanthamoeba keratitis.  Arch Ophthalmol 128: 505, 2010
  32. Tailor UA and Epstein RJ: Corneal ectasia after laser in situ keratomileusis after laser thermal keratoplasty.  Cornea 29: 480, 2010
  33. Epstein, RJ and Epstein RH: Cataract and Refractive Surgery Today European Edition (CRST), 10/16- “Cover Focus: Meet the Epstein Family”, pp. 2-4.
  34. Epstein, RJ and Epstein RH: Cataract and Refractive Surgery Today US Edition (CRST), Feb., 2017- Cover Focus: “Family Tree”. ‘The Epsteins’- Vol. 17, pp. 41-46
  35. Brennan, K, Editor: Cover Focus- “Is Cross-linking at a Crossroads?”, Review of Ophthalmology, Spt. 2017, pp. 23-28.

BOOK REVIEWS

  1. Epstein RJ: Re: Brightbill F, “Corneal Surgery. Theory, Technique, and Tissue, 2nd Edition”. Am J Ophthalmol 547: 1994.
  2. Epstein RJ, Majmudar P: “Excimer Lasers in Ophthalmology. Principles and Practice.” Miller N, McGhee C, Taylor H, Gartry D, Trokel S., Boston, MA. Am J Ophthalmol, 1997.

MEETING PRESENTATIONS with PUBLISHED ABSTRACTS

(ARVO, ASCRS, CLAO, AAO, EBAA/Cornea Society, and OMIG)

  1.  5/80     ARVO, Orlando, FL.  Epstein RJ and Hughes WF:  “Corneal neovascularization induced by Con-A stimulated lymphocytes”.  Invest Ophthalmol Vis Sci 18:26 (Suppl..) 1980.
  2. 5/81     ARVO, Sarasota, FL.  Epstein RJ and Hughes WF:  “Histopathology of corneal neovascularization induced by Con-A stimulated lymphocytes”.  Invest Ophthalmol Vis Sci 20:171, (Suppl..) 1981.
  3. 5/83:    ARVO, Sarasota, FL.  Epstein RJ, Miller MT, Sugar J, Dennis RF, Karpik AG, Sugar A, Pinchoff BS, Gammon JA:  Mesenchymal dysgenesis associated with the fetal alcohol syndrome”.  Invest Ophthalmol Vis Sci 24:275, (Suppl..) 1983.
  4. 5/85     ARVO, Sarasota, FL.  Epstein RJ and Stulting RD: Lymphocyte-induced corneal neovascularization in inbred mice.  Invest Ophthal. Vis Sci 26:317, (Suppl.) 1985.
  5. 9/85:    AAO, San Francisco, CA.  Epstein RJ, Fernandes A, Stulting RD, Tigges M, Wright JD, and Gammon JA.  “The correction of aphakia in neonatal monkeys with extended-wear contact lenses”.   Ophthalmol 92:96, (Suppl..) 1985.
  6. 1/86:    CLAO, Las Vegas, NV. Epstein RJ, Fernandes A, Stulting RF, et al.  “The correction of aphakia in neonatal monkeys with extended-wear contact lenses: corneal studies”.  CLAO J 12:47, (Suppl..) 1986.
  7. 4/86:    ARVO, Sarasota, FL , Epstein RJ and Stulting RD:  “Genetic control of corneal neovascularization (CNV) is dominantly inherited and non-H-2”.  Invest Ophthalmol Vis Sci 27:46, (Suppl..) 1986.
  8. 4/86:    ARVO, Sarasota, FL.  Kindle JC, Epstein RJ, and Stulting RD:  “Cell-mediated immunity to Herpes simplex virus (HSV) in inbred mice”.  Invest Ophthal. Vis Sci 27:116, (Suppl..), 1986.
  9. 4/86:   ARVO, Sarasota, FL.  Halkias A, Epstein RJ, Stulting RD, Rodrigues M: Corneal opacities in DBA/2J mice”.  Invest Ophth. Vis Sci 27:203, (Suppl..) 1986.
  10. 11/86   AAO, New Orleans, LA.  Epstein RJ, Dreizen NG, Stulting RD, Seedor JA, Wilson LA, Cavanagh HD.  “Penetrating Keratoplasty (PK) for Herpes simplex keratitis (HSK) and keratoconus”.  Ophthalmol 93:96 (Suppl..) 1986.
  11. 11/86   AAO, New Orleans, LA.  Seedor JA, Stulting RD, Epstein RJ, Nay RE, Dreizen NG, Waring GO, Wilson LA, and Cavanagh HD.  “Survival of corneal grafts from donors supported by mechanical ventilation”.  Ophthalmol 93:114 (Suppl..) 1986.
  12. 11/86   AAO, New Orleans, LA.   Moore MB, McCulley JP, Bowman RW, Newton C, Cobo LM, O‘Day D, Johns K, Driebe WT, Epstein RJ, Wilson LA, Doughman DJ.  “Acanthamoeba keratitis A growing problem in soft and hard contact lens wearers”.  Ophthalmol 93:116 (Suppl..) 1986.
  13. 4/87     World Cornea Congress III,; Washington DC. Epstein RJ: Corneal vascularization: Causes and prevention. Cornea 6:51 (Suppl..) 1987.
  14. 4/87     World Cornea Congress III, : Washington DC. Stulting RD, Abghari SZ, Epstein RJ, Nahmias AJ: Host control of Herpes simplex (Type I) ocular infection in a genetically defined model. Cornea 6: 158 (Suppl..) 1987
  15. 5/87     ARVO, Sarasota, FL.  Epstein RJ, Stulting RD, and Hendricks RL: Corneal neovascularization in A/J mice induced by Interleukin-2.  Invest Ophthal Vis Sci 28:98, (Suppl..) 1987.
  16. 5/87     ARVO, Sarasota, FL.  Hendricks RL and Epstein RJ:  Bilateral ocular disease induced by unilateral corneal infection with HSV-1.  Invest Ophthalmol Vis Sci 28:368, (Suppl..) 1987.
  17. 11/87   Eye-Bank Association of America, Dallas, TX.  Seedor JA, Walsh GE, Wells JA, McCarty BE, Stulting RD, Epstein RJ and Smith P: “Corneas from ventilator supported donors:  Endothelial morphology and results of a survey”.  (Cornea Suppl. 1988)
  18. 11/87   AAO, Dallas, TX.  Epstein RJ, Fernandes A, and Gammon JA:  Extended-wear contact lenses for the correction of aphakia in infant children:  Corneal studies.  Ophthalmol 94:145, (Suppl..) 1987.
  19. 5/88     ARVO, Sarasota, FL.  Epstein RJ, Hendricks RL, Harris DM, Maloney JA:  “Dihematoporphyrin ether photodynamic therapy (DHE-PDT) for IL-2-induced 1 corneal neovascularization (CNV). Invest Ophthalmol Vis Sci 29:65 (Suppl..) 1988.
  20. 5/88     ARVO, Sarasota, FL.  Lekas NE , Epstein RJ, Harris DM, Hendricks RL:  Fluorescence microscopy of  vascularized corneas following injection of dihematoporphyrin ether (DHE).  Invest Ophthalmol Vis Sci 29:50 (Suppl..), 1988.
  21. 5/88     ARVO, Sarasota, FL.  Tumpey TM, Epstein RJ, Hendricks RL:  The effect of cellular immune tolerance on the immunopathology of HSV-1 keratitis.  Invest Ophthalmol Vis Sci 29:160 (Suppl..) 1988.
  22. 5/89     ARVO, Sarasota, FL.  Epstein RJ, Hendricks RL, Harris DM:  Photodynamic therapy (PDT) with the 514 nm argon laser for IL-2-induced corneal neovascularization (CNV). Invest Ophthalmol Vis Sci 30 (Suppl..):  364, 1989.
  23. 11/89   AAO, New Orleans, LA.   Epstein RJ: Problem patients in contact lens fitting: The monocular aphakic infant.  Ophthalmol 96 (Suppl..) 1989.
  24. 11/89   Castroviejo Society Meeting, New Orleans, LA.   Kay MD, Epstein RJ, Torczynski E:  Acute intraoperative suprachoroidal hemorrhage (AISH) associated with trans-scleral fixation of a posterior chamber IOL at the time of penetrating keratoplasty. (Cornea Suppl.1990)
  25. 10/90   American Academy of Ophthalmology (AAO) Annual Meeting, Atlanta, GA: Holland EJ, Alul EH, Epstein RJ, Meisler DM:  Anterior stromal infiltrates in Acanthamoeba keratitis. (Ophthalmol AAO Suppl.)
  26. 10/90   AAO, Atlanta, GA.  “Microsurgical keratoplasty: A practical course”- Lab Instructor, “Spherical correction of refractive errors”, “Clinical keratoplasty technique”- Lab Instructor. (Ophthalmol AAO Suppl.)
  27. 10/91   AAO, Anaheim, CA: “Microsurgical keratoplasty: A practical course”. Lab instructor. (Ophthalmol. AAO Suppl.)
  28. 10/91   Castroviejo Cornea Society; Anaheim, CA: “Photodynamic therapy for corneal neovascularization.”
  29. 11/92   AAO, Dallas, TX. Instructor- Microsurgical keratoplasty: A practical course. Lab course instructor.  (Ophthalmol AAO Suppl.)
  30. 5/91     ARVO, Sarasota, FL.  Robin SB, Rubenstein JB, Kay MD, Epstein RJ:  Haptic location of trans-sclerally fixated posterior chamber intraocular lenses in the cadaver eye.  Invest Ophthalmol Vis Sci 32:796 (Suppl..) 1991.
  31. 5/91     ARVO, Sarasota, FL.  Riley SF, Epstein RJ, Rubenstein JB, Dennis RJ:  Use of the Terry keratometer to aid suture adjustment with the single running technique.  Invest Ophthalmol Vis Sci 32:1236 (Suppl..), 1991.
  32. 5/91     ARVO, Sarasota, FL.  Gordon J, Johnson PJ, and the Fibronectin Study Group; Discontinuation of topical ophthalmic medications promotes healing of non-healing corneal epithelial defects. Invest Ophthalmol Vis Sci 32:1071 (Suppl..) 1991.
  33. 10/91   American Academy of Optometry, Eiden SB, Bass SJ, Epstein RJ: “Unilateral circumscribed posterior keratoconus” Optom Vis Sci 68:190 (Suppl..) 1991.
  34. 3/92     ARVO: Sarasota, FL. Robin SB, Epstein In the right eye, Rubenstein JB, Eiden SB, Waring GO: Corneal intraepithelial neoplasia: Bilateral disease and its association with contact lens wear.” Invest Ophthalmol Vis Sci 33:1292 (Suppl..), 1992.
  35. 11/92   AAO, Dallas, TX. Robin SB, Epstein RJ, Rubenstein JB, Eiden SB, Waring GO: Corneal intraepithelial neoplasia (CIN): Bilateral disease and its association with contact lens wear. Ophthalmology 99:122 (Suppl..) 1992.
  36. 11/93   AAO, Chicago, IL. Curnyn, KM, Rubenstein JB, Deutsch TA , Epstein RJ: Common office presentations of conjunctival lymphomas. Ophthalmol 1993;100 (Suppl..): 128.
  37. 11/93   Castroviejo Society; Chicago, IL. Capsulorhexis and the triple procedure. Cornea Suppl., 13: 98-99, 1994
  38. 3/94     ARVO; Sarasota, FL. Raphtis EM, Epstein RJ, Torczynski E, Rubenstein JB: Immunohistochemistry for the non-invasive diagnosis of epithelial downgrowth following penetrating keratoplasty. Invest Ophthalmol Vis Sci 35:1875 (Suppl..), 1994.
  39. 3/94     ARVO; Sarasota, FL. Hennessey MJ, Epstein RJ: Photodynamic therapy for corneal neovascularization (CNV): Clinical trials. Invest Ophthalmol Vis Sci 35: 1350 (Suppl..), 1994.
  40. 10/94   AAO, San Francisco, CA. Van Meter WS, Epstein RJ, Wood TO: Corneal astigmatism following removal of adjusted continuous keratoplasty suture, (Suppl..), Ophthalmol 101:123, 1994
  41. 10/95   AAO, Atlanta GA.  Epstein RJ, Konowal A, Dennis RF:  Application of computerized videokeratoscopy in guiding suture removal in post-penetrating keratoplasty patients. (Ophthalmol AAO Suppl.)
  42. 10/95   AAO meeting, Atlanta, GA: “Radial keratotomy on trial: Witness for the defense-speed of visual recovery and stability in RK”. (Ophthalmol AAO Suppl.)
  43. 5/96     Konowal A, Epstein RJ, Dennis RF, Brown SVL: “Irreversible corneal decompensation in patients treated with topical Dorzolamide.” Invest Ophthalmol & Vis Sci (ARVO Suppl.) 37:3, 1996.
  44. 10/96   AAO, Chicago, IL., Brown SVL, Epstein, RJ, Stock EL, Rubenstein J.  Scientific poster presentation:  Results of combined Ahmed valve and penetrating keratoplasty surgery. (Ophthalmol AAO Suppl.)
  45. 10/96   AAO, Chicago, IL. Lecturer with hands-on wet-lab:  Modern incisional refractive surgery.  (Ophthalmol AAO Suppl.)
  46. 10/96   AAO, Chicago, IL: Lecturer: Central Islands with the Summit Apex excimer laser. (Ophthalmol AAO Suppl.)
  47. 10/96   OMIG meeting (AJO Abstract), Epstein RJ, Nguygen, K: Thygeson’s superficial punctate keratitis in children and its response to trifluorothymidine”
  48. 10/96   AAO; Chicago, IL.   Mack RJS, Cutarelli P, Rubenstein JB, Mangan RB , Deutsch TA, Epstein RJ, Dune DS:  Central islands with the Summit Apex excimer laser, Ophthalmology (Suppl.) 1996; 103:129
  49. 3/97     ASCRS, Boston, MA: “PRK Complications: Management and Prevention”.
  50. 5/97     ARVO; Fort Lauderdale, FL.  Hahn S, Moore CR, Gaynes BL, Epstein RJ: Hyperopic Automated Lamellar Keratoplasty (H-ALK): Refractive and Visual Outcome in 41 Eyes. Invest Ophthalmol Vis Sci Suppl. (B772), 1979
  51. 3/98     Castroviejo Cornea Society; Majmudar PA, Brenart R, Epstein RJ: Topical Mitomycin-C for subepithelial fibrosis following RK. Cornea 17:2, 1998.
  52. 10/98   Konowal A, Epstein RJ, Dennis RF, Brown SVL: Poster: “Irreversible corneal decompensation in patients treated with topical Dorzolamide.” (AAO Ophthalmol. Suppl.)
  53. 11/98   Ocular Microbiology and Immunology Group OMIG); New Orleans, LA. Karp KO, Epstein RJ. Delayed keratitis following laser in-situ keratomileusis. Cornea Suppl. 18:3. 1999
  54. 11/98   Castroviejo Society Meeting, New Orleans, LA: Karp K, Epstein RJ.: “Pigmentary dispersion following laser in-situ keratomileusis (LASIK)”. Cornea 18: Suppl., 1999
  55. 10/99   AAO, Orlando FL. “Topical mitomycin-C treatment for corneal haze following refractive surgery”. (Ophthalmol. AAO Suppl.)
  56. 10/99   AAO, Orlando FL. “Breakfast with the experts” moderator- “LASIK Complications: Management and Avoidance”. (Ophthalmol. AAO Suppl.)
  57. 10/99   AAO, Orlando FL. Breakfast with the experts moderator-“LASIK techniques” (Ophthalmol. AAO Suppl.)
  58. 10/99   AAO, Orlando FL. “Astigmatism in the cataract patient”- Lab instructor (Ophthalmol. AAO Suppl.)
  59. 10/00   Raviv T, Rao S, Majmudar PA, Epstein RJ: “Visual outcomes of early flap slips after LASIK”, Ophthalmol (AAO supplement.), 10/2000
  60. 10/00   AAO; Dallas, TX. Co-presenter, skills transfer program, lab:  “Astigmatism in the Cataract Patient”. (Ophthalmol AAO Suppl.)
  61. 10/00   AAO; Dallas, TX. Discussant:  “The role of instrument sterilization and maintenance in DLK”. (Ophthalmol AAO Suppl.)
  62. 11/01   AAO, New Orleans LA. Lab instructor: “Astigmatism in the cataract patient”.  (Ophthalmol AAO Suppl.)
  63. 11/01   AAO, New Orleans, LA. Refractive Surgery Interest Group (RSIG) meeting: “Hansatome Pearls”.
  64. 5/02     ASCRS, Philadelphia, PA:
    1. “The use of Mitomycin-C in refractive corneal surgery”-(course)
    2. -“Mitomycin-C for corneal haze-PRO argument”
  65. 10/02   AAO: “The use of Mitomycin-C after laser refractive surgery”. Course instructor (AAO Ophth. Suppl.)
  66. 10/02   AAO, Orlando FL: “Astigmatism in the cataract patient”. Lab instructor. AAO Ophth. Suppl.)
  67. 10/02   AAO/Castroviejo Society Meeting, Orlando FL: “Mitomycin-C with PTK for Flap Complications”- Laura Muller, MD (Cornea suppl.)
  68. 4/03     ASCRS, San Francisco, CA.:
  69. “The expanding Role of Mitomycin-C in refractive corneal surgery”.
  70. “Design Review of Zyoptix System for LASIK Personalized Vision Correction”.
  71. 5/03     ARVO: Candal EM, Muller LT, Lane HA, Epstein RJ, Dennis RF, Majmudar PA:
  72. “Prophylactic Mitomycin-C for High-Risk PRK & LASEK. Invest Ophthal & Vis Sci 2003 (ARVO suppl.): 108.
  73. 11/03   AAO, Anaheim CA: ISRS/AAO pre-AAO meeting: “The role of antimetabolites in corneal refractive surgery”.
  74. 11/03   AAO, Anaheim CA: B&L Booth: “The Zyoptix system for personalized vision correction”
  75. 11/03   AAO, Anaheim CA: Poster #P0247: Klein, SR, Epstein RJ et. Al: “Poor visual outcomes following corneal refractive surgery in patients with clinically unsuspected pellucid marginal degeneration”.
  76. 11/03   AAO, Anaheim CA: Discussion of paper “Risk factors for corneal ectasia after LASIK” (by Randleman, et. al).
  77. 11/03   AAO, Anaheim CA: Lab instructor:”Astigmatism in the cataract patient” Course LAB250a.
  78. 11/03   AAO, Anaheim CA: Course co-instructor, “The use of mitomycin-C after laser refractive surgery”. Course #566
  79. 4/04     ASCRS, San Diego CA, -Candal, EM, Epstein RJ et.al.: “Role of wavefront analysis in screening keratoconus suspects before refractive corneal surgery”
  80. -Klein, SR, Epstein, RJ et al: “Comparison of time applications of mitomycin-C for haze prophylaxis in PRK”
  81. -Trattler, W, Amoils SP, Epstein RJ, Krueger RR, Hardten D, Smolek M: “Pearls for avoiding ectasia after LASIK” (course)
  82. -Majmudar PA, Carones F, Epstein RJ, Vigo L, Lee D, Zolotaryov A:
  83. “Expanding role of mitomycin-C in refractive surgery” (course)
  84. 10/04   AAO, New Orleans LA:Lab instructor:”Astigmatism in the cataract patient” Course LAB248b
  85. 11/04   AAO, New Orleans, LA: Course co-instructor, “The use of mitomycin-C after laser refractive surgery”. Course #183
  86. 10/04   AAO, New Orleans LA: Course Director, B&:L Hansatome certification course
  87. 10/04   AAO, New Orleans LA: JJ Bausch Ophthalmology Innovators Symposia Series: “Zyoptix Symposium, featuring Zyoptix Dual Workstation and Advanced Diagnostics: Would you do this case? Zyoptix in my practice.”
  88. 4/05     ASCRS, Washington, DC:
  89. -Trattler, W, Swanson MA, Hardten DR, Amoils P, Boxer Wachler B, Smolek,  M, Epstein RJ: ”Ectasia: Risk factors and treatment options“ (course)
  90. -Majmudar PA, Epstein RJ, Netto M, Carones F, Lee DH, Vigo L, Zolotaryov A: “Update on the role of Mitomycin-C in Refractive Surgery” (course).
  91. 10/05   AAO, Chicago, IL: Course Co-instructor, “Astigmatism in the cataract patient”, Course #LAB244a
  92. 10/05   AAO, Chicago, IL: Course Co-instructor, “The use of mitomycin C after laser refractive surgery”, Course #462
  93. 3/06     ASCRS, San Francisco CA:
    1. Course instructor: “Surface ablation for complicated Post-refractive Surgery and Postsurgical eyes (Course #18-403).
    2. Panelist: “Cataract Section: Cataract challenges, AMD lenses, LAL, CTR”
  94. 11/06   ISRS/AAO, Las Vegas, NV: Invited presentation: “Treating buttonhole LASIK flaps”.
  95. 11/06   AAO, Las Vegas, NV: Course Co-instructor, “Astigmatism in the cataract patient”, Course #LAB349b
  96. 11/06   AAO, Las Vegas NV: Course Co-instructor, “The use of mitomycin C after laser refractive surgery”, Course #574
  97. 11/07   AAO, New Orleans , LA: Course Co-instructor, “Astigmatism in the cataract patient”, Course #116
  98. 11/07   AAO, New Orleans , LA: Co-Author, “Reduced application time for prophylactic Mitomycin-C in High-Risk Surface Ablation” (with Virasch VV, Majmudar PA, Dennis Rf, and Vaidya NS)
  99. 11/08   AAO, Atlanta GA: Course Co-instructor, “Astigmatism in the cataract patient”, Course #230a
  100. 10/09   AAO, San Francisco CA: Course Co-instructor, “Astigmatism in the cataract patient”
  101. 10/10   AAO, Chicago. Course Co-instructor, “Astigmatism in the cataract patient”
  102. 3/11     ASCRS, San Diego: Course co-instructor, #29-104: “Advances in corneal                                      collagen crosslinking for keratoconus, post-LASIK ectasia, and corneal infections
  103. 10/11   AAO, Orlando FL: Course Co-instructor, “Astigmatism in the cataract patient”
  104. 10/11   AAO, Orlando FL: Poster #363 Co-author: Rubinfeld RS, Trattler WB, Majmudar PA, Epstein RJ, Adi M, Wallace D, McCall TL, Martin NF, Letko E, Intili A, Perez G: “Multicenter evaluation of epithelial-on vs epithelial-off corneal collagen crosslinkng for keratoconus and pos-LASIK ectasia”.
  105. 10/11   AAO, Orlando FL: Cornea Day pre-AAO invited presentation: “Corneal topography and tomography interpretation for the cataract surgeon: Implications for premium IOL’s”
  106. 10/11   AAO, Orlando FL: Cornea Society presentation co-author: Rubinfeld R, Trattler W, Epstein R, Forstot L, Talamo J, Khell J, Perez G: “Multicenter comparative evaluation of epithelium-on cross-linking vs epithelium-off corneal collagen cross-linking (CXL)
  107. 4/12   ASCRS Chicago: “Anterior segment complications after glaucoma surgery (Cornea Society symposium)
  108. 5/10/12 ARVO, Ft. Lauderdale FL: Rubinfeld R, Trattler W, Perez, G, Kaiser C, Koreishi A, Majmudar P, Epstein RJ, Bafna S, Malahotra R- “Outcomes following epithelium-on crosslinking in patients who received the treatment on one or both eyes”- 6786/D950
  109. 11/12   AAO, Chicago IL: Co-instructor, “Astigmatism in the cataract patient”
  110. 4/13   ASCRS, San Francisco CA: Course instructor “Mastering transepithelial and epi-off corneal CXL for keratoconus and post-LASIK ectasia (course #1536796)
  111.   5/13   ARVO, Seattle WA: Tannan, A, Epstein, Jonathan Rubenstein; Vanee Virasch; Charles Faron, O.D: “Utility of intraoperative wavefront aberrometry in post-refractive cataract patients” (pres. #3004, poster #C0095).
  112.   5/13   ARVO, Seattle WA: Raciti, M, Epstein, RJ, et al:” Corneal Endothelial Cell Density Following Transepithelial Collagen Cross-Linking” (Abstract # 1564125)
  113. 10/13   ESCRS, Amsterdam: Roy Rubinfeld, MD, William Trattler, MD, Rosane Correa, MD, Gabriela Perez BS, Randy Epstein, MD, Gregg Berdy, MD, Ranjan Malahotra, MD: “Evaluation of Epi-On Corneal Collagen Cross-Linking (CXL) at 6 months and 1 year Follow Up in Patients Diagnosed with Keratoconus”
  114. 4/14     ASCRS, Boston MA: Course # 28-106: “Early Detection and Management of Keratoconus Including Collagen Crosslinking”
  115. 10/14   AAO, Chicago IL:
  116. Keynote Lecture, ISRS pre-AAO “Refractive Surgery 2014”:
    • “Mitomycin-C: Uses and Abuses in Corneal Refractive Surgery”
    • Great Debate: Corneal Crosslinking: “Epithelium-on” (SYM11)
    • Course LAB143a: “Toric alignment imaging and astigmatism surgery”
    • Course LAB107a: “Crosslinking”
  117. 11/15   AAO, Las Vegas NV: Lab instructor: “LAB 125a- Toric alignment imaging and astigmatism surgery” and “LAB 104a- Crosslinking”
  118. 10/16   AAO, Chicago IL: Lab instructor: “LAB 134a- Toric alignment imaging and astigmatism surgery”
  119. 11/17   AAO, New Orleans LA: Lab instructor: “LAB 145a: Toric alignment imaging and astigmatism surgery”
  120. 4/18     ASCRS, Washington, DC- Lab co-instructor, Surgical Management of Astigmatism Skills Lab, Course STS-2
  121. 5/18     ARVO, Honolulu HI: Poster #2875470 co-author: “Demystifying DMEK: A comparison of donor preparation”: Epstein R, Majmudar, PA, Epstein RJ, Rubenstein, JB
  122. 10/18   AAO, Chicago IL: Lab instructor “Lab 142a-  Toric Alignment Imaging and Astigmatism Surger
  123. 5/18     Poster presentation, “PDEK: Is it any better than DMEK?” American Society of Cataract and Refractive Surgery, San Diego, CA, May 2019.
  124. 5/18     ASCRS, San Diego CA: Lab co-instructor, Surgical Management of Astigmatism Skills Lab, Course STS-2
  125. 10/19   AAO, San Francisco CA: Lab instructor “Lab 142a-  Toric Alignment Imaging and Astigmatism Surgery
  1. AUDIO-VISUAL EDUCATIONAL MATERIALS
  2. Epstein RJ.  “Refractive Practice Pearls”.  Audio-Digest Ophthalmology 41:12. 2/03.
  3. Epstein RJ. “LASIK Complications, Antimetabolites and Refractive Surgery.” “The Management of Astigmatism with Cataract Surgery”.   Audio-Digest Ophth. 5/03.
  4. Epstein RJ.  “Expanding Applications for NSAIDs:  The Inflammatory Response in the Eye”.  Audioconference series, 7/03-10/03.

PATENTS and INVENTIONS

The “Epstein-Lindstrom aspirating LASIK lid speculum”, #E-4118, (Storz/B&L Surgical patent)

ONLINE PUBLICATIONS

  1. 2/10/2020: MSN.com  Joan Raymond US Yesterday • 2:33 PM
  2. 5 eye problems you shouldn’t ignore, from floaters to pains
LASIK eye surgery is a procedure that is designed to reduce your dependency on eyeglasses and contact lenses. Here at Chicago Cornea Consultants™, our LASIK surgeons and eye doctors use the latest in laser vision correction technology to ensure each patient receives optimal results.
Woman going for a run after LASIK
LASIK/
Laser Eye Surgery
As leaders in the field of ophthalmology, we were among the first in the area to offer the advanced Alcon LenSx laser platform for cataract surgery. This exciting new technology allows our skilled ophthalmologists to make incredibly precise modifications, enhancing the patient experience.
Elderly couple relaxing after Cataract Surgery
Advanced Cataract
Surgery
Traditionally, presbyopia, which happens to all of us as we age, has always meant glasses for clear reading vision. It's a condition not even correctable by laser vision correction. Luckily, there is an option. Refractive lens exchange allows patients a clear alternative to reading glasses and is capable of reducing or eliminating presbyopia by using an advanced multifocal intraocular lens.
Refractive Lens Exchange
refractive lens
exchange/phakic iol's
Keratoconus describes a cornea that weakens as collagen fibers deteriorate, causing the cornea to adapt a cone-like shape. Keratoconus can cause blurred vision, light sensitivity, glares, and decreased night vision. In its early stages, keratoconus may be treated with the use of prescription glasses or contact lenses. Keratoconus is also one of the most common reasons for corneal transplant, and one of the most successful. Call any of our offices and ask to speak to the Vision Correction Surgical Coordinator, or use the contact form below.
Closeup of the Cornea
cornea/
keratoconus
It's estimated that a million or more Americans have glaucoma and don't even know it. People with glaucoma often do not experience any symptoms until they begin losing their peripheral vision. One of the scariest things about glaucoma is that it usually has no symptoms in the early stages, earning glaucoma the name "silent thief of sight." Anyone can be at risk, so it's important to have your vision regularly examined.
Elderly couple smiling after Glaucoma treatment
glaucoma
At Chicago Cornea Consultants™, our doctors take great care in maintaining ocular health for our patients. However, a number of our patients voice concerns regarding soft lines and wrinkles around the eyes and other regions of the face. We have responded by introducing cosmetic procedures like BOTOX® Cosmetic through our Chicago practice.
Woman posing after BOTOX
botox®
cosmetic
Dry eye can result from a lack of sufficient production of your own natural tears, with an inability to provide adequate lubrication for your eyes. This can cause mild to severe discomfort including itching, stinging and burning. Dry eyes are a common concern in Chicago, and the experienced team of corneal specialists at Chicago Cornea Consultants™ have the latest advancements in technology to treat dry eye.
older woman smiling
Dry Eye
Contact lenses are medical devices which interact directly with the ocular surface of the eye. At Chicago Cornea Consultants™, we provide exceptional care to ensure that you obtain the best possible vision with contact lenses that fit appropriately and maximize health benefits.
Mature Man Having an Eye Exam
Contact
Lenses
(800) 8-CORNEA
Online Bill Pay Request an Appointment Cataract Self-Test LASIK Self-Test